IMB Dx, Inc. (KOSDAQ:461030)
South Korea · Delayed Price · Currency is KRW 2,685.00
+90.00 (3.47%)
Sep 22, 2026, 3:30 PM KST
IMB Dx Market Cap
IMB Dx has a market cap or net worth of 36.38 billion as of September 22, 2026. Its market cap has decreased by -75.05% in one year.
Market Cap
36.38B
Enterprise Value
18.73B
Revenue
5.60B
Ranking
n/a
PE Ratio
n/a
Stock Price
2,685.00
ChartMarket Cap Chart
Since April 3, 2024, IMB Dx's market cap has decreased from 503.73B to 36.38B, a decrease of -92.78%. That is a compound annual growth rate of -65.48%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 22, 2026 | 37.64B | -72.85% |
| Dec 30, 2025 | 138.64B | -7.14% |
| Dec 30, 2024 | 149.29B | -70.36% |
| Apr 3, 2024 | 503.73B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Genexine | 131.89B |
| Vaxcell-Bio Therapeutics | 101.52B |
| MedPacto | 93.23B |
| iNtRON Biotechnology | 87.42B |
| Prestige BioPharma | 69.95B |
| ENCell | 65.85B |
| Amicogen | 62.56B |
| ORIENT BIO | 54.13B |